Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence setting release_7fwzwudbrnh75jqfjcsgwze4cq

by Katherine Bond, Suellen Nicholson, Seok Lim, Theo Karapanagiotidis, Eloise Williams, Douglas Johnston, Tuyet Hoang, Cheryll Sia, Damian Purcell, Sharon Lewin, Mike Catton, Benjamon P Howden (+1 others)

Cited By

References to this release by other works.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 4 of 4 references (in 176ms)

via crossref
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2 [post]
Thomas S. Fulford, Huy Van, Nicholas A. Gherardin, Shuning Zheng, Marcin Ciula, Heidi E. Drummer, Samuel Redmond, Hyon-Xhi Tan (+ more)
2021    unpublished
web.archive.org [PDF]

via crossref
Severe acute respiratory syndrome-coronavirus 2 in domesticated animals and its potential of transmission: A meta-analysis
Yos Adi Prakoso, Chylen Setiyo Rini, Yuli Purwandari Kristianingrum, Nurul Hidayah, Dyah Widhowati, Miarsono Sigit
2021   Veterinary World
doi:10.14202/vetworld.2021.2782-2792  pmcid:PMC8654752  pmid:34903940 
web.archive.org [PDF]

via grobid
Low post-pandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia [post]
I Sam, Yoong Chong, Chee Tan, Yoke Chan
2020    unpublished
web.archive.org [PDF]

via fatcat-pubmed
Antibody testing for coronavirus disease 2019: not ready for prime time
Yen T Duong, Connor G Wright, Jessica Justman
2020   The BMJ (British Medical Journal)
doi:10.1136/bmj.m2655  pmcid:PMC7332962  pmid:32620675 
web.archive.org [PDF]